Few Eyebrows Up

Nov 02, 2018

Some experts have raised concerned about 23andMe's new direct-to-consumer pharmacogenetic tests, Time reports.

The US Food and Drug Administration earlier this week gave 23andMe authorization to sell tests for 33 variants linked to the ability to break down certain drugs, as GenomeWeb has reported.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Ways to Make the Move

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

Fire at Russian Pathogen Lab

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Proteins From the Past

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

PNAS Studies Look at Diabetes Susceptibility, S. Aureus Subpopulations, More

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.

Menu

Few Eyebrows Up

To read the full story....

The Scan

Ways to Make the Move

Fire at Russian Pathogen Lab

Proteins From the Past

PNAS Studies Look at Diabetes Susceptibility, S. Aureus Subpopulations, More

What's Popular?

10x Genomics CEO Says Firm 'Ready for Growth' Following $357.5M IPO

LunaPBC Partners With Medfusion to Integrate EHR, Genomic Data-Sharing Platform

Aethlon Medical Lands $1.9M SBIR Grant for Exosome Isolation Device

Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA

Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers

Sponsorships